Armour Thyroid NDC 0456-0462

NDC codes

FDA NDC Directory

Product NDC (as listed)0456-0462Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00456-0462Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0456-0462-01	00456046201	100 TABLET in 1 BOTTLE (0456-0462-01)Marketed from Apr 1, 1996

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Armour Thyroid
Generic name (nonproprietary): thyroid, porcine
Active ingredients: Sus scrofa thyroid — 180 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Allergan, Inc.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Apr 1, 1996
Listing expires: Dec 31, 2027
Identifiers: Product ID 0456-0462_e0335861-1654-4a32-92dd-d875ba0c5fcaSPL ID e0335861-1654-4a32-92dd-d875ba0c5fcaSPL set ID 56b41079-60db-4256-9695-202b3a65d13dRxCUI 198278, 208534, 208535, 208540, 208543, 208544, 208545, 208547, 208549, 208551, 313385, 313387, 313391, 313393, 314267, 315235UNII 6RV024OAUQ

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400456046201 followed by a unit qualifier and the quantity

Package 00456-0462-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 1, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Armour Thyroid (thyroid tablets, USP) are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)